Cuprina Holdings (Cayman) Limited (CUPR) vs Femasys Inc. (FEMY)

Cuprina Holdings (Cayman) Limited and Femasys Inc. are both Medical Instruments & Supplies companies. Femasys Inc. is the larger, with a market value of $20.4M against $10.6M — 1.9× the size. Across the 5 metrics below, Cuprina Holdings (Cayman) Limited leads on 3 and Femasys Inc. on 2.

Valuation

Metric CUPR FEMY Medical Instruments & Supplies median
P/E — n/m 34.17
P/S — 3.62 2.83
P/B n/m 2.07 2.82
Price to free cash flow — n/m 25.69
EV/EBITDA n/m n/m 16.08
EV/Sales n/m 4.57 3.06
Earnings yield — (142.34%) (1.84%)
Free cash flow yield — (217.10%) 0.17%

Profitability

Metric CUPR FEMY Medical Instruments & Supplies median
Gross margin — 60.95% 54.62%
Operating margin — (763.90%) 1.64%
Net margin — (534.27%) 0.00%
Free cash flow margin — (786.02%) 1.61%
Return on equity — (443.65%) 0.00%
Return on assets — (94.25%) 0.00%
Return on invested capital 0.00% (176.91%) 0.00%

Growth

Metric CUPR FEMY Medical Instruments & Supplies median
Revenue growth (TTM) — 21.85% 9.20%
EPS growth (last fiscal year) (200.00%) 44.71% —
Revenue growth, 5-year CAGR — 17.18% 9.48%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric CUPR FEMY Medical Instruments & Supplies median
Debt to equity 0.07 0.90 0.08
Current ratio 2.35 2.14 2.49
Net debt to EBITDA 0.57 0.23 0.83

Dividend

Metric CUPR FEMY Medical Instruments & Supplies median
Dividend yield — — 0.99%
Payout ratio — 0.00 0.00

Size

Metric CUPR FEMY Medical Instruments & Supplies median
Market cap 10.64m 20.35m 938.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack